SCHEMBL5013360

SCHEMBL5013360

Cc1ccc(OCc2n[c]cs2)cc1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.55
SIRT1 Q96EB6 1/20 0.41
NPC1 O15118 6/20 0.40
HSP90AA1 P07900 1/20 0.40
MAPT P10636 4/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
HTT P42858 2/20 0.39
POLB P06746 2/20 0.39
ESR1 P03372 1/20 0.39
TP53 P04637 1/20 0.39
APEX1 P27695 1/20 0.39
MAPK1 P28482 1/20 0.39
ESR2 Q92731 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HPN P05981 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6002923 0.87 RAB9A (0.45) RAB9ASIRT1NPC1HSP90AA1MAPT
SCHEMBL2094591 0.84 RAB9A (0.37) RAB9ANPC1MAPTL3MBTL1HTT
SCHEMBL2096161 0.79 APP (0.48) RAB9ANPC1MAPTCYP1A2CYP3A4
SCHEMBL2097746 0.76 NPC1 (0.48) RAB9ANPC1MAPTTP53MEN1
SCHEMBL2095891 0.76 APP (0.42) RAB9ANPC1TDP1KMT2ASMN1; SMN2
SCHEMBL2749917 0.74 HAO1 (0.41) RAB9ANPC1MAPTL3MBTL1HTT
SCHEMBL2091188 0.73 APP (0.35) RAB9ANPC1HSP90AA1MAPTL3MBTL1
SCHEMBL3734938 0.71 RAB9A (1.00) RAB9ASIRT1NPC1MAPTL3MBTL1
SCHEMBL12337966 0.70 RAB9A (0.57) RAB9ANPC1HSP90AA1MAPTL3MBTL1
SCHEMBL17931583 0.69 RAB9A (0.55) RAB9ANPC1HSP90AA1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
EP-1678185-B1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMA CO LTD (JP) 2008-10-08 EP disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed